CRISPR-Cas9 is a modern gene-editing technology that allows precise modification of targeted DNA regions. Through this method, defective genes can be corrected or specific gene activities can be altered. FDA-approved CRISPR-based therapies already exist for diseases such as sickle cell anemia and beta thalassemia. CRISPR is considered a major breakthrough in making gene therapy more precise, faster, and increasingly personalized.